Posts by: Marisa Wexler, MS

Marisa Wexler, MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

January 17, 2020January 17, 2020

Biogen Acquiring Pfizer’s Investigational Therapy PF-05251749 for Alzheimer’s, Parkinson’s Symptoms

News

Biogen is acquiring from Pfizer investigational therapy PF-05251749, a small molecule being developed to treat sundowning in Alzheimer’s disease and irregular sleep wake rhythm disorder (ISWRD) in Parkinson’s disease. The ... Read more

December 6, 2019December 6, 2019

Repeat Coding in Gene Region Linked to Risk of Late-onset Alzheimer’s, Study Suggests

News

Longer sequence repeats in or near two genes may be linked to a higher risk of late-onset Alzheimer’s disease, a study reports. The study “Alzheimer Disease Pathology-Associated Polymorphism in ... Read more

November 26, 2019November 26, 2019

Phase 2 Trial to Test New Way of Measuring Tau Plaques in Living Brains

News

A newly opened Phase 2 clinical trial will test the sensitivity of new imaging tool for plaque buildup in the brains of people with mild cognitive impairment and dementia ... Read more

November 4, 2019November 4, 2019

High-salt Diet can Cause Dementia by Promoting Accumulation of Tau Plaques, Mouse Study Says

News

A diet that is high in salt can cause dementia in mice by promoting a buildup of plaques of the protein tau, which is also associated with Alzheimer’s disease, ... Read more

September 25, 2019September 25, 2019

Electromagnetic Device Improves Cognition in Alzheimer’s Patients, Small Study Finds

News

NeuroEM Therapeutics‘s MemorEMTM — a head-worn device that uses electromagnetic waves — has shown promising results in a preliminary clinical trial of people with mild-to-moderate Alzheimer’s disease. Seven of ... Read more

September 18, 2019September 18, 2019

Bryostatin-1 Fails to Ease Dementia in Moderate-to-Severe Alzheimer’s Patients in Phase 2 Trial

News

An investigational Alzheimer’s treatment called bryostatin-1 failed to meet its primary goal — lesser evidence of dementia in people with more severe disease — in a Phase 2 clinical ... Read more

September 17, 2019

FTC Warns Companies Against Unsubstantiated Advertising of CBD Products for Fibromyalgia

News

The U.S. Federal Trade Commission (FTC) sent warning letters to three companies that sell cannabis-based products containing cannabidiol (CBD), cautioning them that making unsubstantiated claims about the health benefits ... Read more

September 4, 2019September 4, 2019

ATXN1 Gene Tied to Rare Disorder Regulates Key Enzyme in Alzheimer’s

News

A gene associated with a rare balance disorder also may be involved in susceptibility to Alzheimer’s disease, a new study in mice shows. The study, “Loss of Ataxin-1 Potentiates ... Read more

August 28, 2019August 28, 2019

Understanding Protein Aggregation May Aid Quest for Better Alzheimer’s Treatments

News

Better understanding the mathematics behind how protein clumps form — and how therapies interfere with this process — may improve treatment strategies for Alzheimer’s, and other diseases, new research ... Read more

July 22, 2019July 22, 2019

Having Close Relatives With Alzheimer’s is Linked to Worse Memory, Study Says

News

Having close relatives with Alzheimer’s disease is linked to poorer memory, a new study has found. The study, titled “Family history of Alzheimer’s disease alters cognition and is modified ... Read more

Pin It on Pinterest